Clinical trial
Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas
NCT07222735 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas
- Lead sponsor
- St. Jude Children's Research Hospital
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- January 21, 2026
- Completion date
- November 5, 2031
- Enrollment
- 42 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
childhood osteosarcoma, childhood rhabdomyosarcoma, childhood soft tissue sarcoma, ewing sarcoma, sarcoma